Equillium files prospectus supplement for up to $75 million stock offering
PositiveFinancial Markets

Equillium has filed a prospectus supplement for a stock offering that could raise up to $75 million. This move is significant as it indicates the company's confidence in its growth potential and ability to attract investors. The funds raised could be used to further develop their innovative therapies, which is crucial for their future success and expansion in the biotech industry.
— Curated by the World Pulse Now AI Editorial System